Cargando…
Building up a genomic surveillance platform for SARS-CoV-2 in the middle of a pandemic: a true North–South collaboration
Next-generation sequencing technology has revolutionised pathogen surveillance over the last two decades. However, the benefits are not equitably distributed, with developing countries lagging far behind in acquiring the required technology and analytical capacity. Recent declines in the cost associ...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660681/ https://www.ncbi.nlm.nih.gov/pubmed/37984892 http://dx.doi.org/10.1136/bmjgh-2023-012589 |
_version_ | 1785148422623330304 |
---|---|
author | Khan, Waqasuddin Kabir, Furqan Kanwar, Samiah Aziz, Fatima Muneer, Sahrish Kalam, Adil Rajab Ali, Mehdia Nadeem Ansari, Nadia Vanaerschot, Manu Ahyong, Vida Fahsbender, Liz Kalantar, Katrina Black, Allison Glascock, Abigail Gil, Juliana Ayscue, Patrick Tato, Cristina Jehan, Fyezah Nisar, Imran |
author_facet | Khan, Waqasuddin Kabir, Furqan Kanwar, Samiah Aziz, Fatima Muneer, Sahrish Kalam, Adil Rajab Ali, Mehdia Nadeem Ansari, Nadia Vanaerschot, Manu Ahyong, Vida Fahsbender, Liz Kalantar, Katrina Black, Allison Glascock, Abigail Gil, Juliana Ayscue, Patrick Tato, Cristina Jehan, Fyezah Nisar, Imran |
author_sort | Khan, Waqasuddin |
collection | PubMed |
description | Next-generation sequencing technology has revolutionised pathogen surveillance over the last two decades. However, the benefits are not equitably distributed, with developing countries lagging far behind in acquiring the required technology and analytical capacity. Recent declines in the cost associated with sequencing—equipment and running consumables have created an opportunity for broader adoption. During the COVID-19 pandemic, rapid diagnostics development and DNA sequencing revolutionised the ability to diagnose and sequence SARS-CoV-2 rapidly. Socioeconomic inequalities substantially impact the ability to sequence SARS-CoV-2 strains and undermine a developing country’s pandemic preparedness. Low- and middle-income countries face additional challenges in establishing, maintaining and expanding genomic surveillance. We present our experience of establishing a genomic surveillance system at the Aga Khan University, Karachi, Pakistan. Despite being at a leading health sciences research institute in the country, we encountered significant challenges. These were related to collecting standardised contextual data for SARS-CoV-2 samples, procuring sequencing reagents and consumables, and challenges with library preparation, sequencing and submission of high-quality SARS-CoV-2 genomes. Several technical roadblocks ensued during the implementation of the genomic surveillance framework, which were resolved in collaboration with our partners. High-quality genome sequences were then deposited on open-access platforms per the best practices. Subsequently, these efforts culminated in deploying Pakistan’s first SARS-CoV-2 phyllo surveillance map as a Nextstrain build. Our experience offers lessons for the successful development of Genomic Surveillance Infrastructure in resource-limited settings struck by a pandemic. |
format | Online Article Text |
id | pubmed-10660681 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-106606812023-11-19 Building up a genomic surveillance platform for SARS-CoV-2 in the middle of a pandemic: a true North–South collaboration Khan, Waqasuddin Kabir, Furqan Kanwar, Samiah Aziz, Fatima Muneer, Sahrish Kalam, Adil Rajab Ali, Mehdia Nadeem Ansari, Nadia Vanaerschot, Manu Ahyong, Vida Fahsbender, Liz Kalantar, Katrina Black, Allison Glascock, Abigail Gil, Juliana Ayscue, Patrick Tato, Cristina Jehan, Fyezah Nisar, Imran BMJ Glob Health Practice Next-generation sequencing technology has revolutionised pathogen surveillance over the last two decades. However, the benefits are not equitably distributed, with developing countries lagging far behind in acquiring the required technology and analytical capacity. Recent declines in the cost associated with sequencing—equipment and running consumables have created an opportunity for broader adoption. During the COVID-19 pandemic, rapid diagnostics development and DNA sequencing revolutionised the ability to diagnose and sequence SARS-CoV-2 rapidly. Socioeconomic inequalities substantially impact the ability to sequence SARS-CoV-2 strains and undermine a developing country’s pandemic preparedness. Low- and middle-income countries face additional challenges in establishing, maintaining and expanding genomic surveillance. We present our experience of establishing a genomic surveillance system at the Aga Khan University, Karachi, Pakistan. Despite being at a leading health sciences research institute in the country, we encountered significant challenges. These were related to collecting standardised contextual data for SARS-CoV-2 samples, procuring sequencing reagents and consumables, and challenges with library preparation, sequencing and submission of high-quality SARS-CoV-2 genomes. Several technical roadblocks ensued during the implementation of the genomic surveillance framework, which were resolved in collaboration with our partners. High-quality genome sequences were then deposited on open-access platforms per the best practices. Subsequently, these efforts culminated in deploying Pakistan’s first SARS-CoV-2 phyllo surveillance map as a Nextstrain build. Our experience offers lessons for the successful development of Genomic Surveillance Infrastructure in resource-limited settings struck by a pandemic. BMJ Publishing Group 2023-11-19 /pmc/articles/PMC10660681/ /pubmed/37984892 http://dx.doi.org/10.1136/bmjgh-2023-012589 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Practice Khan, Waqasuddin Kabir, Furqan Kanwar, Samiah Aziz, Fatima Muneer, Sahrish Kalam, Adil Rajab Ali, Mehdia Nadeem Ansari, Nadia Vanaerschot, Manu Ahyong, Vida Fahsbender, Liz Kalantar, Katrina Black, Allison Glascock, Abigail Gil, Juliana Ayscue, Patrick Tato, Cristina Jehan, Fyezah Nisar, Imran Building up a genomic surveillance platform for SARS-CoV-2 in the middle of a pandemic: a true North–South collaboration |
title | Building up a genomic surveillance platform for SARS-CoV-2 in the middle of a pandemic: a true North–South collaboration |
title_full | Building up a genomic surveillance platform for SARS-CoV-2 in the middle of a pandemic: a true North–South collaboration |
title_fullStr | Building up a genomic surveillance platform for SARS-CoV-2 in the middle of a pandemic: a true North–South collaboration |
title_full_unstemmed | Building up a genomic surveillance platform for SARS-CoV-2 in the middle of a pandemic: a true North–South collaboration |
title_short | Building up a genomic surveillance platform for SARS-CoV-2 in the middle of a pandemic: a true North–South collaboration |
title_sort | building up a genomic surveillance platform for sars-cov-2 in the middle of a pandemic: a true north–south collaboration |
topic | Practice |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660681/ https://www.ncbi.nlm.nih.gov/pubmed/37984892 http://dx.doi.org/10.1136/bmjgh-2023-012589 |
work_keys_str_mv | AT khanwaqasuddin buildingupagenomicsurveillanceplatformforsarscov2inthemiddleofapandemicatruenorthsouthcollaboration AT kabirfurqan buildingupagenomicsurveillanceplatformforsarscov2inthemiddleofapandemicatruenorthsouthcollaboration AT kanwarsamiah buildingupagenomicsurveillanceplatformforsarscov2inthemiddleofapandemicatruenorthsouthcollaboration AT azizfatima buildingupagenomicsurveillanceplatformforsarscov2inthemiddleofapandemicatruenorthsouthcollaboration AT muneersahrish buildingupagenomicsurveillanceplatformforsarscov2inthemiddleofapandemicatruenorthsouthcollaboration AT kalamadil buildingupagenomicsurveillanceplatformforsarscov2inthemiddleofapandemicatruenorthsouthcollaboration AT rajabalimehdianadeem buildingupagenomicsurveillanceplatformforsarscov2inthemiddleofapandemicatruenorthsouthcollaboration AT ansarinadia buildingupagenomicsurveillanceplatformforsarscov2inthemiddleofapandemicatruenorthsouthcollaboration AT vanaerschotmanu buildingupagenomicsurveillanceplatformforsarscov2inthemiddleofapandemicatruenorthsouthcollaboration AT ahyongvida buildingupagenomicsurveillanceplatformforsarscov2inthemiddleofapandemicatruenorthsouthcollaboration AT fahsbenderliz buildingupagenomicsurveillanceplatformforsarscov2inthemiddleofapandemicatruenorthsouthcollaboration AT kalantarkatrina buildingupagenomicsurveillanceplatformforsarscov2inthemiddleofapandemicatruenorthsouthcollaboration AT blackallison buildingupagenomicsurveillanceplatformforsarscov2inthemiddleofapandemicatruenorthsouthcollaboration AT glascockabigail buildingupagenomicsurveillanceplatformforsarscov2inthemiddleofapandemicatruenorthsouthcollaboration AT giljuliana buildingupagenomicsurveillanceplatformforsarscov2inthemiddleofapandemicatruenorthsouthcollaboration AT ayscuepatrick buildingupagenomicsurveillanceplatformforsarscov2inthemiddleofapandemicatruenorthsouthcollaboration AT tatocristina buildingupagenomicsurveillanceplatformforsarscov2inthemiddleofapandemicatruenorthsouthcollaboration AT jehanfyezah buildingupagenomicsurveillanceplatformforsarscov2inthemiddleofapandemicatruenorthsouthcollaboration AT nisarimran buildingupagenomicsurveillanceplatformforsarscov2inthemiddleofapandemicatruenorthsouthcollaboration |